Profiel
Carl M.
Mendel was Vice President of Clinical Development and Chief Medical Officer of Synvista Therapeutics, Inc. from September 2007 to December 19, 2008.
He was Assistant Professor of Medicine for the University of California, San Francisco.
Dr. Mendel joined the pharmaceutical industry in 1993 and held various positions at Merck, Knoll and Aventis.
He was Vice President of Metabolism Projects for sanofi-aventis.
Dr. Mendel received a BA from Columbia University in New York and an MD from the University of California, San Diego.
He did his post-graduate training in Internal Medicine at LAC/USC Medical Center in Los Angeles and Endocrinology and Metabolism at the University of California, San Francisco.
Eerdere bekende functies van Carl M. Mendel
| Bedrijven | Functie | Einde |
|---|---|---|
| SYNVISTA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 19-12-2008 |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | - |
| The University of California, San Francisco | Corporate Officer/Principal | - |
Opleiding van Carl M. Mendel
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| University of California San Diego | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SYNVISTA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Health Technology |
